Disease Activity Score in 28 joints using C-reactive protein based remission state and still residual swollen joints: theoretically possible, but does it occur in the real world? [PDF]
Pascal M.W. Groenen +3 more
openalex +1 more source
The retinoic acid binding protein CRABP2 is increased in murine models of degenerative joint disease [PDF]
Ian Welch +3 more
openalex +1 more source
Objective Antinuclear antibodies (ANAs) are present at high titers in 2% of the general population, but their clinical significance in individuals without an autoimmune (AI) disease is not known. We tested the hypothesis that the presence of a high ANA titer in non‐AI conditions is associated with disease.
Matthew Chung +7 more
wiley +1 more source
Anti-inflammatory effects of an injectable copolymer of fatty acids (Ara 3000 beta®) in joint diseases [PDF]
Catherine Baugé +5 more
openalex +1 more source
Objective This study assessed sarilumab in treating patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods This phase 2b, open‐label study (NCT02776735) consisted of three sequential parts (each with a core‐treatment and extension‐phase). During part 1, three doses were assessed in two weight groups (Group A/B: ≥30–60 kg/≥10–<
Fabrizio De Benedetti +19 more
wiley +1 more source
Targeting mitochondrial oxidative stress: A novel therapeutic strategy for degenerative joint diseases (Review). [PDF]
Hou Y, Yang X, Zhao T, Guo Y, Shi J.
europepmc +1 more source
Targeting CD44 Receptor Pathways in Degenerative Joint Diseases: Involvement of Proteoglycan-4 (PRG4). [PDF]
Qadri MM.
europepmc +1 more source
REHABILITATION OF PATIENT WITH RHEUMATIC DISEASES AFTER ENDOPROSTHETICS OF BIG JOINTS
В П Павлов +4 more
openalex +1 more source
The Federal Bureau of Investigation/Centers for Disease Control and Prevention Joint Criminal and Epidemiological Investigations Course: Enhancing Relationships to Improve Biothreat Readiness [PDF]
Kaoru Hayashi, Stephen Papagiotas
openalex +1 more source
Objective A patient‐centered approach for chronic disease management, including systemic lupus erythematosus (SLE), aligns treatment with patients’ values and preferences, leading to improved outcomes. This paper summarizes how patient experiences, perspectives, and priorities informed the American College of Rheumatology (ACR) 2024 Lupus Nephritis (LN)
Shivani Garg +20 more
wiley +1 more source

